FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281479861> ?p ?o ?g. }

• W4281479861 endingPage "528" @default.
• W4281479861 startingPage "518" @default.
• W4281479861 abstract "Medication adherence to concomitant oral antidiabetics, statins, and renin-angiotensin system (RAS) antagonists (triple therapy) is vital to manage glycated hemoglobin (A1C) and low-density lipoprotein cholesterol (LDL-C) control among patients with comorbid diabetes, hyperlipidemia, and hypertension. The objective of the current study was to evaluate the association between adherence to concomitant triple therapy and A1C as well as LDL-C outcomes, among elderly patients using marginal structural modeling.A retrospective cohort study with patients on concurrent triple therapy was conducted using a Texas Medicare Advantage database from January 2016 until December 2019. Medication adherence to concurrent triple therapy was measured every 6 months using proportion of days covered (PDC) to determine the different adherence groups. A1C and LDL-C control was also measured every 6 months. A marginal structural model controlling for baseline covariates and time-varying confounders affected by prior adherence was conducted to evaluate the association between adherence to concomitant triple therapy and A1C and LDL-C control.The LDL-C cohort was comprised of 4803 patients and the A1C cohort was comprised of 5314 patients on triple therapy. Patients who were adherent to triple therapy [odds ratio(OR):1.84, 95% confidence interval (CI): 1.62-2.10] and adherent to double therapy (OR:1.42, 95% CI: 1.24-1.62) were more likely to have their LDL-C in control as compared to patient's adherent to monotherapy/none. Similarly, patients who were adherent to triple therapy (OR:1.30, 95% CI: 1.11-1.52) and adherent to double therapy (OR:1.32, 95% CI: 1.12-1.55) were more likely to have their A1C in control as compared to patient's adherent to monotherapy/none.The current study demonstrated the beneficial effects of adherence to concurrent oral antidiabetics, statins, and RAS antagonists among elderly patients in a real-world setting." @default.
• W4281479861 created "2022-05-26" @default.
• W4281479861 creator A5022807028 @default.
• W4281479861 creator A5024324680 @default.
• W4281479861 creator A5038798689 @default.
• W4281479861 creator A5041208258 @default.
• W4281479861 creator A5044760063 @default.
• W4281479861 creator A5048234700 @default.
• W4281479861 creator A5083105414 @default.
• W4281479861 date "2022-06-09" @default.
• W4281479861 modified "2023-10-16" @default.
• W4281479861 title "Evaluating Adherence to Concomitant Diabetes, Hypertension, and Hyperlipidemia Treatments and Intermediate Outcomes Among Elderly Patients Using Marginal Structural Modeling" @default.
• W4281479861 cites W1845225129 @default.
• W4281479861 cites W1976400433 @default.
• W4281479861 cites W1992952302 @default.
• W4281479861 cites W1995511200 @default.
• W4281479861 cites W2001617346 @default.
• W4281479861 cites W2008557562 @default.
• W4281479861 cites W2009187570 @default.
• W4281479861 cites W2018629886 @default.
• W4281479861 cites W2039714102 @default.
• W4281479861 cites W2044383241 @default.
• W4281479861 cites W2057829663 @default.
• W4281479861 cites W2059944344 @default.
• W4281479861 cites W2063558977 @default.
• W4281479861 cites W2068725670 @default.
• W4281479861 cites W2083430604 @default.
• W4281479861 cites W2104344587 @default.
• W4281479861 cites W2112683812 @default.
• W4281479861 cites W2125409901 @default.
• W4281479861 cites W2137015334 @default.
• W4281479861 cites W2140817333 @default.
• W4281479861 cites W2148273290 @default.
• W4281479861 cites W2158943274 @default.
• W4281479861 cites W2162311034 @default.
• W4281479861 cites W2167576798 @default.
• W4281479861 cites W2303875786 @default.
• W4281479861 cites W2319839537 @default.
• W4281479861 cites W2331305984 @default.
• W4281479861 cites W2339800103 @default.
• W4281479861 cites W2562550696 @default.
• W4281479861 cites W2582461952 @default.
• W4281479861 cites W2583862987 @default.
• W4281479861 cites W2740859753 @default.
• W4281479861 cites W2752775068 @default.
• W4281479861 cites W2771663153 @default.
• W4281479861 cites W2780610639 @default.
• W4281479861 cites W2801131290 @default.
• W4281479861 cites W2957653719 @default.
• W4281479861 cites W3004775519 @default.
• W4281479861 cites W4250208868 @default.
• W4281479861 doi "https://doi.org/10.1002/phar.2705" @default.
• W4281479861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35611624" @default.
• W4281479861 hasPublicationYear "2022" @default.
• W4281479861 type Work @default.
• W4281479861 citedByCount "0" @default.
• W4281479861 crossrefType "journal-article" @default.
• W4281479861 hasAuthorship W4281479861A5022807028 @default.
• W4281479861 hasAuthorship W4281479861A5024324680 @default.
• W4281479861 hasAuthorship W4281479861A5038798689 @default.
• W4281479861 hasAuthorship W4281479861A5041208258 @default.
• W4281479861 hasAuthorship W4281479861A5044760063 @default.
• W4281479861 hasAuthorship W4281479861A5048234700 @default.
• W4281479861 hasAuthorship W4281479861A5083105414 @default.
• W4281479861 hasConcept C126322002 @default.
• W4281479861 hasConcept C134018914 @default.
• W4281479861 hasConcept C156957248 @default.
• W4281479861 hasConcept C167135981 @default.
• W4281479861 hasConcept C201903717 @default.
• W4281479861 hasConcept C2776999253 @default.
• W4281479861 hasConcept C2777180221 @default.
• W4281479861 hasConcept C2777538456 @default.
• W4281479861 hasConcept C2779091943 @default.
• W4281479861 hasConcept C2779384505 @default.
• W4281479861 hasConcept C44249647 @default.
• W4281479861 hasConcept C555293320 @default.
• W4281479861 hasConcept C71924100 @default.
• W4281479861 hasConcept C72563966 @default.
• W4281479861 hasConceptScore W4281479861C126322002 @default.
• W4281479861 hasConceptScore W4281479861C134018914 @default.
• W4281479861 hasConceptScore W4281479861C156957248 @default.
• W4281479861 hasConceptScore W4281479861C167135981 @default.
• W4281479861 hasConceptScore W4281479861C201903717 @default.
• W4281479861 hasConceptScore W4281479861C2776999253 @default.
• W4281479861 hasConceptScore W4281479861C2777180221 @default.
• W4281479861 hasConceptScore W4281479861C2777538456 @default.
• W4281479861 hasConceptScore W4281479861C2779091943 @default.
• W4281479861 hasConceptScore W4281479861C2779384505 @default.
• W4281479861 hasConceptScore W4281479861C44249647 @default.
• W4281479861 hasConceptScore W4281479861C555293320 @default.
• W4281479861 hasConceptScore W4281479861C71924100 @default.
• W4281479861 hasConceptScore W4281479861C72563966 @default.
• W4281479861 hasIssue "7" @default.
• W4281479861 hasLocation W42814798611 @default.
• W4281479861 hasLocation W42814798612 @default.
• W4281479861 hasOpenAccess W4281479861 @default.
• W4281479861 hasPrimaryLocation W42814798611 @default.
• W4281479861 hasRelatedWork W1584443261 @default.

• next